Retrospective Study of the Use of Belantamab Mafodotin (Blenrep®) in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM) in Spain.

NCT05297240 · clinicaltrials.gov ↗
UNKNOWN
Status
170
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

PETHEMA Foundation

Collaborators